All In Biotech

Drug Trial Radar · NCT02800785

The Comparison of Outcomes of Antibiotic Drugs and Appendectomy (CODA) Trial

Last checked: Nov 19, 2026Latest source record: May 6, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 1,552 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,552

Actual

Start

May 2016

Primary completion

Mar 5, 2020

Study completion Sep 1, 2021

Sponsor

Lead sponsor
University of WashingtonAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Patient-Centered Outcomes Research Institute
First posted
Jun 15, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

For the past 130 years, appendectomy has been the standard treatment for appendicitis. Recent studies from Europe have challenged the notion that surgery is the best option, showing that antibiotics alone can treat appendicitis without a need for appendectomy in as many as 3 out of 4 patients and without safety issues for up to one year of follow up. Despite these results, it remains to be determined if the antibiotic strategy is as good as an appendectomy for the outcomes that most patients care about. The Patient-Centered Outcomes Research Institute (PCORI)-funded Comparison of Outcomes of Drugs and Appendectomy (CODA) trial will be the first American, and largest-ever randomized trial of the issue and its results should help surgeons and patients make more informed healthcare decisions.

Conditions

  • Appendicitis

Interventions

  • Cefoxitin, Ertapenem, Moxifloxacin, Tigecycline, Ticarcillin-Clavulanic Acid; Metronidazole plus Cefazolin, Cefuroxime, Ceftriaxone, Cefotaxime, Ciprofloxacin, or LevofloxacinDrug

    Patients will be offered a treatment regimen of antibiotics based on guidelines published jointly by the Surgical Infection Society and the Infectious Disease Society of America. After IV antibiotics are administered for a period of at least 24 hours, a regimen of oral antibiotics will be continued for a total treatment length of 10 days. Preferred oral antibiotic regimens include Moxifloxacin alone, and combinations such as Metronidazole or Clindamycin, for anaerobic bacteria coverage, plus Ciprofloxacin or Levofloxacin, or an oral Cephalosporin for aerobic Gram-negative bacteria coverage.

  • AppendectomyProcedure

    Appendectomy will be performed by an open or laparoscopic approach, depending on patient and surgeon preference.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Patient-reported Quality of Life as Measured by EuroQol (EQ-5D)Time frame: Four-weeks after randomization

Locations

25 sites in 1 country. Site status is shown where the registry gives one.

  • Olive View-UCLA Medical Center

    Sylmar, California

  • Harbor-UCLA Medical Center

    Torrance, California

  • University of Colorado Denver

    Aurora, Colorado

  • Rush University Medical Center

    Chicago, Illinois

  • University of Iowa Hospitals and Clinics

    Iowa City, Iowa

  • Maine Medical Center

    Portland, Maine

  • Boston Medical Center

    Boston, Massachusetts

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts

  • Michigan Medicine- University of Michigan

    Ann Arbor, Michigan

  • Henry Ford Health System

    Detroit, Michigan

  • University of Mississippi Medical Center

    Jackson, Mississippi

  • New York University - Bellevue Hospital

    New York, New York

  • New York University - Tisch Hospital

    New York, New York

  • Columbia University Medical Center

    New York, New York

  • Weill Cornell Medicine

    New York, New York

  • The Ohio State University Medical Center

    Columbus, Ohio

  • Vanderbilt University Medical Center

    Nashville, Tennessee

  • Lyndon B Johnson- Harris Health

    Houston, Texas

  • The University of Texas Health Science Center at Houston

    Houston, Texas

  • Providence Regional Medical Center Everett

    Everett, Washington

  • Harborview Medical Center

    Seattle, Washington

  • Virginia Mason University Village Medical Center

    Seattle, Washington

  • Swedish Medical Center- First Hill

    Seattle, Washington

  • University of Washington Medical Center

    Seattle, Washington

  • Madigan Army Medical Center

    Tacoma, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.